Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

INDUSTRY × Pyloric Stenosis, Hypertrophic × BMS-833923 × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Leukemia 2 Stomach Neoplasms 1 Pyloric Stenosis, Hypertrophic 1 Neoplasms 1 Leukemia, Myeloid, Chronic-Phase 1 Esophageal Neoplasms 1 Carcinoma, Basal Cell 1 Bronchiolitis Obliterans Syndrome 1

Interventions

Lenalidomide 2 tafasitamab 1 brivanib 1 Valganciclovir 1 N,N-dicyclopropyl-4-((1,5-dimethyl-1H-pyrazol-3-yl)amino)-6-ethyl-1-methyl-1,6-dihydroimidazo(4,5-d)pyrrolo(2,3b)pyridine-7-carboxamide 1 Leucovorin 1 Irinotecan 1 Fluorouracil 1 Dexamethasone 1 Bortezomib 1 BMS-833923 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00884546 2016-09-30

Multiple Ascending Dose (MAD) Combination in Subjects With Multiple Myeloma

Bristol-Myers Squibb

Phase 1 Completed

Pyloric Stenosis, Hypertrophic

Data powered by HemOnc (CC BY 4.0) Colophon ⚡